Major changes have occurred in therapeutics for coronavirus-19 (COVID-19) infection over
the past 12–18 mo, most notably in early outpatient therapy. In most cases, solid organ …

Abstract Purpose of Review Coronavirus disease 2019 (COVID-19) is caused by a complex
interplay between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Abstract Coronavirus disease 2019 (COVD-19) emerged as a pandemic in December 2019.
Infection has spread quickly and renal transplant recipients receiving chronic …

Background. Few studies have analyzed differences in clinical presentation and outcomes
in solid organ transplant (SOT) recipients with coronavirus disease 2019 (COVID-19) across …

Since its outbreak in December 2019, the coronavirus disease 2019 (COVID-19) pandemic,
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to an …

Background. Few reports have focused on newer coronavirus disease 2019 (COVID-19)
therapies (remdesivir, dexamethasone, and convalescent plasma) in solid organ transplant …

As in the general population with coronavirus 2019 (COVID-19) infection, therapeutic
interventions in solid organ transplant (SOT) recipients have evolved over time. The …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) arose in December 2019
in China rapidly evolving to the Coronavirus Disease 2019 (COVID-19) pandemic. Since …

Kidney transplantation is the best available renal replacement therapy for patients with end-
stage kidney disease and is associated with better quality of life and patient survival …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has profoundly impacted liver
transplant (LT) activity across the world, with notable decreases in the number of donations …